Cargando…
Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer
Redirected chimeric antigen receptor (CAR) T-cells can recognize and eradicate cancer cells in a major histocompatibility complex independent manner. Genetic engineering of T cells through CAR expression has yielded great results in the treatment of hematological malignancies compared with solid tum...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407156/ https://www.ncbi.nlm.nih.gov/pubmed/34522192 http://dx.doi.org/10.4103/1735-5362.323911 |